Synthego wants to make gene-editing tools more accessible to scientists around the world. To that end, the Bay Area biotech has raised $110 million in series C funding to ramp up capacity for its ...
Scientists have developed an inexpensive new test that can rapidly diagnose COVID-19 infections, a timely advance that comes as clinicians and public health officials are scrambling to cope with ...
BOSTON--(BUSINESS WIRE)--The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today ...
Some genetic diseases are more straightforward than others. In cases like cystic fibrosis or Marfan syndrome, a mutation makes a gene defective, and that causes symptoms in a patient that are ...
CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...
The genome editing technology CRISPR has evolved from the darling of research labs around the world — enabling new types of experiments in a much more efficient way — to the great hope for unlocking ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback